Dr. Waskin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
90 E. Scott Avenue
Building 34
Rahway, NJ 07065
Summary
- MD with Board certified internal medicine/infectious diseases with professional interest in public health epidemiology, fungal diseases, HIV, and immunocompromised host. Expertise in pharmaceutical research as clinical team leader.
Education & Training
- Centers for Disease Control and PreventionFellowship, Infectious Disease, 1985 - 1987
- University of New Mexico School of MedicineFellowship, Infectious Disease, 1984 - 1985
- Rush University Medical CenterResidency, Internal Medicine, 1978 - 1981
- University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
- NC State Medical License 1988 - 2025
- NJ State Medical License 2001 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsA population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia.Gregory Winchell, Rik de Greef, Aziz Ouerdani, Floris Fauchet, Rebecca E Wrishko
Antimicrobial Agents and Chemotherapy. 2024-04-03 - 3 citationsPharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.Johan A Maertens, Galia Rahav, Dong-Gun Lee, Shariq Haider, Isabel Cristina Ramirez-Sanchez
Clinical Drug Investigation. 2023-09-01 - 5 citationsDouble-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III).Thomas J Sferra, Tomas Merta, Michael Neely, Claudia Murta de Oliveira, Alvaro Lassaletta
Journal of the Pediatric Infectious Diseases Society. 2023-06-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: